Almac Pharma Services Extend Formulation Facilities

November 10, 2006

Almac Pharma Services is extending it’s formulation facilities with the opening of a revamped, technology-rich 10,500 ft 2 building, at the company’s United Kingdom headquarters later this month. The enhanced facility represents an investment of $10.5 million and strengthens the company’s offering to the global pharmaceutical and biotechnology industries

The custom-designed facility will operate to full cGMP, providing extended formulation development services in solid oral dosage forms from pre-clinical through to pilot scale. This advancement, will provide classified facilities (ISO 8 / Class 100,000) including laboratories with independent temperature and humidity controlled zones and self-contained suites – many with High Containment capabilities. Our highly skilled scientists can use just milligrams of your valuable API to prepare supplies for first time in-man (FTIM) studies, or can develop and optimise your formulation to progress it through to commercial manufacture.

Almac Pharma Services, President and M.D, Graeme McBurney said the investment represents a significant element of the overall future growth strategy of Pharma Services.

“We at Almac Pharma Services are entering into a new and exciting phase in our development. We are investing to expand the breadth and depth of an already comprehensive suite of commercial services. We work with an increasing number of clients, supporting their needs at each stage of the drug product life cycle, including formulation development, clinical batch production, commercial scale manufacturing, packaging and global supply chain management.”

“The services offered by Almac Pharma Services are world-class and have a global reach. Being part of the Almac ‘family’ means that our staff and our clients have an opportunity to benefit from the entire Almac Group skill-set and infrastructure.”

Almac Chairman Sir Allen McClay said: “The level of investment associated with this move shows our commitment to our operations in Craigavon, as well as Almac’s long term focus on developing fully integrated pharmaceutical services, from drug discovery through to commercialisation.”

Almac Pharma Services, a division of the Almac Group, is headquartered in Craigavon, United Kingdom with offices in Audubon, USA, and is dedicated to continually developing processes and technologies, to remain at the forefront of innovation and to offer comprehensive, flexible, outsourcing solutions from formulation to finished product.



Clare Ward Jim McGibbon
Almac Pharma Services Almac Pharma Services
+44 (0)28 3836 3363 +1 (610) 671 8568

[email protected]

Brendan Mulgrew

Stakeholder Communications

+44 (0)28 9033 9949


Back to news